Css LLC Alnylam Pharmaceuticals, Inc. Call Options Transaction History

Css LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $71,655 - $123,500	500 New	500 $121,000
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $602,100 - $846,450	5,000 New	5,000 $729,000
Q1 2022 May 16, 2022	SELL	$127.18 - $173.91 $635,900 - $869,550	-5,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $797,800 - $1.05 Million	5,000 New	5,000 $848,000

641

108M

2.11M

2.04M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $34.1B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.